Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C.

International journal of immunogenetics - 1 Aug 2012

Marangon A V, Moliterno R A, Sell A M, de Moraes C F V, Grotto R M T, Pardini M C, De Pauli D S, Visentainer J E L, Silva G F

Abstract excerpt

The objective of this study was to analyse the possible role of HLA polymorphism of chronically infected hepatitis C virus patients in the response outcome to treatment with pegylated interferon-alpha plus ribavirin. To that end, 144 Brazilian patients infected only with genotype 1 of the virus were treated with pegylated interferon-alpha at 1.5 μg kg(-1) in conjunction with ribavirin (1000 mg if patient weight...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Genes, MHC Class I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, MHC Class II

Share to Histocompatibility Testing

Share to HLA-DRB1 Chains

Share to Interferon-alpha

Share to Recurrence

Share to Ribavirin

Source

Identifiers

PMID: 22284614
DOI: 10.1111/j.1744-313X.2012.01088.x

Genes

REL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influence of HLA alleles in response to treatment with pegylated interferon-alpha and ribavirin in patients with chronic hepatitis C.PMID 22284614Read ↗

Human leukocyte antigen class II alleles (DQB1 and DRB1) as predictors for response to interferon therapy in HCV genotype 4.Semantic proximity Read ↗

Protective effect of HLA-DRB1 11 and predisposition of HLA-C 04 in the development of severe liver damage in Brazilian patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Distribution of the human leukocyte antigen class II alleles in Brazilian patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.Semantic proximity Read ↗

[HLA class II alleles and response to hepatitis C treatment with interferon alpha2b].Semantic proximity Read ↗

Prognostic effect of human leukocyte antigen class I and II alleles on chronic hepatitis C patients treated by pegylated interferon-alfa plus ribavirin in Taiwan.Semantic proximity Read ↗

HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C virus genotypes, HLA-DRB alleles and their response to interferon-alpha and ribavirin in patients with chronic hepatitis C.Semantic proximity Read ↗

Influence of HLA alleles on outcome of hepatitis C virus infection.Semantic proximity Read ↗

Clinical impact of HLA DR B1 genotypes in chronic hepatitis C virus infection.Semantic proximity Read ↗

Association between HLA class II alleles and hepatitis B virus infection in Transylvania, Romania.Semantic proximity Read ↗

Importance of host genetic factors HLA and IL28B as predictors of response to pegylated interferon and ribavirin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.